Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
8m agoCiveo Corporation Amends Credit Agreement, Increasing Capacity and Extending Maturity to 2030
8m agoUNIFI®, Makers of REPREVE®, Schedules Third Quarter Fiscal 2026 Earnings Conference Call
8m agoButterfield Reports First Quarter 2026 Results
8m agoOklo Announces Date for First Quarter 2026 Financial Results and Business Update Call
9m agoCF Industries Holdings, Inc. Declares Quarterly Dividend

Oryzon Genomics Sa

About

Oryzon Genomics Sa (MC:ORY) — investor relations, events, news, and company updates on 6ix.

Latest News

Feb 27 2026
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
Feb 19 2026
ORYZON to Participate in Upcoming Events in February and March
Feb 12 2026
ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS
Feb 9 2026
ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in Extensive Stage Small Cell Lung Cancer
Feb 2 2026
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan

Financials

Revenue
€10.93 M
Market Cap
€220 M
EPS
-0.03

Community Chat

Ask AI

6ix6ixAIEvents